Jump to: How much weight do people lose on each | How retatrutide and Mounjaro work differently | Side effects compared | What happens if you stop taking the medication | Cost and access in the UK | Cardiovascular and long-term safety | Muscle mass and body composition | Switching considerations | Who should consider which | Frequently asked questions | Take home message | Second Natures Mounjaro programme | References Retatrutide has produced larger weight loss than Mounjaro in trials so far, with an average weight loss of up to 28.7% at 68 weeks in retatrutides TRIUMPH-4 trial, compared with up to 22.5% at 72 weeks in Mounjaros SURMOUNT-1 trial
A 2,700person realworld study presented at the 2025 European Congress on Obesity showed an average of semaglutide
AbstractSection Graphical Abstract Similar content being viewed by others Digital Features This article is published with digital features, including graphical abstract, to facilitate understanding of the article
Expert Opin Ther Pat (2020) 30:78194
10.1016/j.bbamem.2011.12.014 Biochim
The purpose of this review is to provide an analysis of current head-to-head comparative data of GLP-1 RAs and their cardio protective effects, blood glucose control, weight loss, systolic blood pressure reduction and improvement of lipid profile